Skip to main content
. 2020 May 29;59(12):1589–1599. doi: 10.1007/s40262-020-00903-0

Table 1.

Demographics and clinical characteristics

Younger adults
[n = 41]
Elderly
[n = 39]
Age, years [mean (range)] 32.0 (22–45) 68.5 (65–77)
Sex [n (%)]
 Male 28 (68.3) 22 (56.4)
 Female 13 (31.7) 17 (43.6)
White [n (%)] 41 (100.0) 39 (100.0)
Weight, kg [mean (SD)] 78.4 (10.0) 76.7 (12.8)
BMI, kg/m2 [mean (SD)] 24.8 (2.4) 26.2 (2.6)
HbA1c, % [mean (SD)] 7.2 (0.6) 7.2 (0.7)
Duration of T1DM, years [mean (SD)] 17.7 (9.3) 37.5 (14.7)
Total daily insulin dose, units [mean (SD)] 49.2 (15.3) 44.1 (22.8)
Previous insulin therapy [n (%)]
 Basal MDI 24 (58.5) 24 (61.5)
 Rapid-acting MDI 23 (56.1) 22 (56.4)
 Short-acting MDI 0 2 (5.1)
 Mixtard MDI 1 (2.4) 0
 Rapid-acting CSII 17 (41.5) 15 (38.5)

BMI body mass index, CSII continuous subcutaneous insulin infusion, HbA1c haemoglobin A1c, MDI multiple daily injections, SD standard deviation, T1DM type 1 diabetes mellitus